International Hematologic Conference Features UCSF Health Experts
UCSF experts in multiple myeloma and other hematologic malignancies will attend the American Society of Hematology’s (ASH) 64th Annual Meeting and Exposition.
University of California San Francisco
Give to UCSF
How AI Found the Words to Kill Cancer Cells
A new sophisticated machine learning technique using a molecular library of commands guides engineered immune cells to seek out and tirelessly kill cancer cells.
A Blueprint for More Equitable Care in Public Health Crises
Since March 2020, UCSF has partnered with government and community groups to address racial, economic and cultural barriers to provide equitable care to vulnerable people during the COVID-19 pandemic.
International Conference Features UCSF Breast Cancer Experts
UCSF breast cancer experts will present new research and clinical findings at the annual San Antonio Breast Cancer Symposium, the largest and most prestigious breast cancer conference.
Myocarditis in Cancer Patients Is Driven by Specific Immune Cells
Researchers have identified specific immune cells that drive deadly heart inflammation in a small fraction of patients treated with powerful cancer immunotherapy drugs.
Marijuana and E-cigs Can Harm the Heart Like Traditional Cigarettes
E-cigarettes and marijuana have similar harmful effects on the heart as tobacco cigarettes, opening the door to abnormal heart rhythms, reports a team of researchers at UCSF.
“CAR Pooling” Screens Identify Most Effective Cancer Immunotherapy Cells
A new method of comparing massive numbers of CAR-T cells can determine which is most effective and long-lasting against cancer.
Can Gut Microbes Impact Chemotherapy? So Far, the Answer is ‘Yes’
Bacteria in our guts may play a significant role in the metabolism of anti-cancer drugs that are critical for treating colon cancer and other types of cancers.
UCSF Study Sheds Light on the Reasons Behind Sex Differences in Myocarditis
Immune checkpoint inhibitors (ICIs) used in cancer care can cause myocarditis, a potentially fatal side effect, and it appears that the adverse cardiac effects may disproportionally impact female patients.
UCSF’s Nevan Krogan Wins France’s Highest Honor
Nevan Krogan, PhD, director UCSF’s Quantitative Biosciences Institute (QBI) and founder of QBI’s Coronavirus Research Group (QCRG), has been awarded the Legion of Honor, France’s highest honor, in a ceremony in Paris.
UCSF Hosts First Lady Jill Biden to Discuss Breast Cancer Research
First Lady Jill Biden, Ed.D, met with top UCSF cancer leaders during a visit Friday, October 7th, to hear about UCSF’s breast cancer research and progress on the National Cancer Moonshot.
Omicron’s Evolution and the New Bivalent COVID-19 Booster
Last month new “bivalent” booster vaccines made by Moderna and Pfizer became available that protect against currently circulating Omicron variants as well as earlier strains of the SARS-CoV-2 virus that causes COVID-19. This Q&A features Joel Ernst, MD, a UCSF professor of medicine whose research aims to understand how pathogens evade the immune system.
Hackathon Prepares Young Researchers for the Collaborative Science of the Future
On a sunny Friday, teams of aspiring young scientists gathered in the Clinical Sciences building at Parnassus Heights to look for treasure in a trillion data points about cancer.
Drug Turns Cancer Gene Into ‘Eat Me’ Flag for Immune System
A new therapy pulls forward a mutated version of the KRAS protein to help the immune system recognize and destroy cancer cells.
